A New Option for Early Breast Cancer Treatment

Breast cancer is a treatable form of cancer, but few advancements have been made in the field in the last two decades. The drug abemaciclib, or Verzenio, may be the best option for the vast majority of people living with the disease. Verzenio is already being used to treat metastatic breast cancer, but the FDA recently approved it for use in individuals with early breast cancer. Many doctors and scientists are applauding the decision and are hopeful that breast cancer will become less deadly as a result. 

Radiant is published in Print & Digital. Download a free digital edition at radianthealthmag.com/free.